Drugs / BMS-962476
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01587365 | May 2012 → May 2013 | atherosclerosis | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMS-962476 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01587365 ↗ |
| Route | Subcutaneous | “subcutaneously (SC)” NCT01587365 ↗ |